Upgrade to SI Premium - Free Trial

UBS Reiterates Buy Rating on Edwards Lifesciences (EW)

October 8, 2026 9:34 AM
UBS analyst Patrick Wood reiterated a Buy rating and $110.00 price target on Edwards Lifesciences (NYSE: EW).The analyst commented, "Predicting ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments